
The President Wants Cheaper Drugs. His Portfolio Would Like A Second Opinion.
The patient and the shareholder have different definitions of a healthy drug price. The presidency has acquired an interest in both.
Read More →
The patient and the shareholder have different definitions of a healthy drug price. The presidency has acquired an interest in both.
Read More →
The IMF upgraded Africa’s growth outlook while warning that aid cuts, inflation and the next shock could still turn resilience into a very expensive compliment.
Read More →
China and North Korea finally opened a bridge completed in 2014. Concrete moves faster than diplomacy, but apparently only after a twelve-year coffee break.
Read More →
Retail sales rose in September, but the heroic consumer in this story looks suspiciously like a gas pump holding everyone’s wallet hostage.
Read More →
CoreWeave’s bonds slid into distress territory as investors reconsidered the debt beneath the AI buildout. Apparently infinite compute still comes with a monthly payment.
Read More →